Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Aug 15, 2014; 5(4): 471-481
Published online Aug 15, 2014. doi: 10.4239/wjd.v5.i4.471
Published online Aug 15, 2014. doi: 10.4239/wjd.v5.i4.471
Structured SMBG in early management of T2DM: Contributions from the St Carlos study
Teresa Ruiz Gracia, Nuria García de la Torre Lobo, Alejandra Durán Rodríguez Hervada, Alfonso L Calle Pascual, Department of Endocrinology and Nutrition, Hospital Clínico San Carlos, Universidad Complutense, 28040 Madrid, Spain
Author contributions: Ruiz Gracia T wrote the manuscript; García de la Torre Lobo N, Durán Rodríguez Hervada A and Calle Pascual AL revised it and approved the final version; all authors contributed to the work and agreed to it being submitted to the journal.
Correspondence to: Dr. Alfonso L Calle Pascual, Professor, Department of Endocrinology and Nutrition, Hospital Clinico San Carlos, Universidad Complutense, 1ª Sur, 28040 Madrid, Spain. acallepascual@hotmail.com
Telephone: +34-91-3303281 Fax: +34-91-3303140
Received: January 13, 2014
Revised: April 11, 2014
Accepted: May 29, 2014
Published online: August 15, 2014
Processing time: 206 Days and 18.1 Hours
Revised: April 11, 2014
Accepted: May 29, 2014
Published online: August 15, 2014
Processing time: 206 Days and 18.1 Hours
Core Tip
Core tip: Structured self-monitoring of blood glucose (SMBG) has recently become an important component of modern therapy for diabetes mellitus due to its educational and therapeutic role. SMBG aids physicians and patients to achieve a specific level of glycemic control and to prevent hypoglycemia. It empowers patients to achieve nutritional and physical activity goals, and helps physicians to optimize the different hypoglycemic therapies as demonstrated in the St Carlos study.